[HTML][HTML] Emerging therapeutics in the management of COVID-19
The severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019, COVID-
19) pandemic has placed a tremendous burden on healthcare systems globally …
19) pandemic has placed a tremendous burden on healthcare systems globally …
Experimental therapies under investigation for COVID-19
R Golamari, N Kapoor, T Devaraj, N Sahu… - Journal of Community …, 2021 - Taylor & Francis
Coronavirus Disease 2019, caused by the virus, Severe Acute Respiratory Syndrome
Coronavirus-2 (SARS-CoV-2), is a pandemic first discovered in Wuhan, China which has …
Coronavirus-2 (SARS-CoV-2), is a pandemic first discovered in Wuhan, China which has …
A review on the effectivity of the current COVID-19 drugs and vaccines: are they really working against the severe acute respiratory syndrome coronavirus 2 (SARS …
R Noor - Current Clinical Microbiology Reports, 2021 - Springer
Abstract Purpose of Review In order to eradicate the COVID-19 pandemic, scientists around
the world have been working very hard for a year or more with the motto of designing …
the world have been working very hard for a year or more with the motto of designing …
A focus on the nowadays potential antiviral strategies in early phase of coronavirus disease 2019 (Covid-19): A narrative review
C Monari, V Gentile, C Camaioni, G Marino, N Coppola… - Life, 2020 - mdpi.com
Background: The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection and the related disease (COVID-19) has rapidly spread to a pandemic …
CoV-2) infection and the related disease (COVID-19) has rapidly spread to a pandemic …
Medicines for the treatment of COVID-19: Awaiting the evidence
N Marto, EC Monteiro - Acta Médica Portuguesa, 2020 - actamedicaportuguesa.com
The novel severe acute respiratory syndrome coronavirus 2 is the cause of Coronavirus
Disease 2019, a new illness with no effective treatment or vaccine that has reached …
Disease 2019, a new illness with no effective treatment or vaccine that has reached …
Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines
Y Xiao, H Xu, W Guo, Y Zhao, Y Luo, M Wang… - Molecular …, 2020 - Springer
The outbreak of coronavirus disease 2019 (COVID-19) triggered by the new member of the
coronaviridae family, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has …
coronaviridae family, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has …
Potential drug candidates underway several registered clinical trials for battling COVID-19
The emergence of new type of viral pneumonia cases in China, on December 31, 2019;
identified as the cause of human coronavirus, labeled as “COVID-19,” took a heavy toll of …
identified as the cause of human coronavirus, labeled as “COVID-19,” took a heavy toll of …
In vitro data of current therapies for SARS-CoV-2
IA Anastasiou, I Eleftheriadou… - Current Medicinal …, 2020 - ingentaconnect.com
Background: In December 2019, a new coronavirus, named Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2), emerged from China, causing pneumonia …
Syndrome Coronavirus 2 (SARS-CoV-2), emerged from China, causing pneumonia …
A review of potential treatments to date in COVID-19 patients according to the stage of the disease
T Alsuliman, L Alasadi, B Alkharat, M Srour… - Current Research in …, 2020 - Elsevier
Introduction and motivation Since the end of 2019, the COVID-19 pandemic has affected
millions of people worldwide. With the rapid spread of this virus, an immense burden has …
millions of people worldwide. With the rapid spread of this virus, an immense burden has …